What is Rubicon Research Ltd (RUBICON) share price today?

Rubicon Research Ltd (RUBICON) is listed on the NSE. Visit VestAI at https://www.vestai.io/stocks/RUBICON for the latest live price, technical analysis, and AI-powered insights.

How to analyse RUBICON stock?

VestAI provides comprehensive RUBICON stock analysis including RSI, MACD, Bollinger Bands, SMA trend, ROCE, debt-to-equity ratio, and smart money holdings by superstar investors.

What sector is Rubicon Research Ltd in?

Rubicon Research Ltd (RUBICON) is in the Healthcare sector, Pharmaceuticals industry on the NSE.

Rubicon Research Ltd

RUBICON

NSE· Healthcare

₹1,431.40

+24.20 (+1.72%)

Updated 12:33 pm IST

52W Low · ₹570.7552W High · ₹1,468.70

Near 52W High

Market Cap

₹19811.22L Cr

Volume

1.90L

Prev Close

₹1,407.20

ISIN

INE506V01022

VestAI Stock Score

VALUATION

Moderate

D/E 0.88x — manageable leverage

QUALITY

High Quality

ROCE 23.8% — excellent capital efficiency

MOMENTUM

Neutral

RSI 68.0 — consolidating

Price Chart

SMA 20

SMA 50

SMA 200

Key Fundamentals

Q4 FY2026

P/E Ratio: 78.75
ROCE: 23.81%
ROE (1Y): 28.90%
D/E Ratio: 0.88x
OPM: 20.71%
TTM EPS: ₹15.27
Dividend Yield: 0.00%
Qtrly Sales: ₹513.91 Cr
Qtrly Profit: ₹76.78 Cr

Technical Signals

Quarterly Results

Revenue & Profit in ₹ Crores

Revenue Net Profit

Quarter	Revenue	Net Profit	OPM	EPS
Q4 2026	₹513.91	₹76.78	20.7%	₹4.60
Q3 2026	₹475.53	₹72.8	20.3%	₹4.41
Q4 2025	₹358.15	₹36.24	17.5%	₹2.20
Q3 2025	₹313.4	₹38.07	19.3%	₹2.31

Peer Comparison — Healthcare

Top companies in the same sector by market cap

Company	Mkt Cap	P/E	ROCE	ROE	D/E	OPM
RUBICON ★	₹19,811 Cr	78.75	23.81%	28.90%	0.88x	20.71%
SUNPHARMASun Pharmaceutical Industries	₹4,27,609 Cr	37.32	15.73%	14.72%	0.06x	18.90%
CIPLACipla Limited	₹1,16,281 Cr	29.99	13.66%	11.74%	0.02x	9.50%
MAXHEALTHMax Healthcare Institute	₹95,110 Cr	66.21	11.94%	14.33%	0.32x	22.56%
AUROPHARMAAurobindo Pharma Limited	₹90,029 Cr	25.94	12.55%	9.93%	0.21x	15.11%
ABBOTINDIAAbbott India Limited	₹57,724 Cr	36.63	36.14%	34.46%	0.04x	27.01%

Shareholding Pattern

Q1 FY2027

Promoter

77.6%

FII

6.31%

DII

5.17%

Public

10.92%

Quarter-over-Quarter Trend

Quarter	Promoter	FII	DII	Public
Q1 FY2027	77.6% ↑	6.31% ↓	5.17% ↓	10.92% ↓
Q3 FY2026	59.99%	7.99%	9.45%	22.57%

Corporate Actions

No recent corporate actions

Funds Holding This Stock

31 mutual fund schemes

PGIM India Healthcare Fund Direct GrowthDHFL_PRAMERICA

5.97%

₹6 Cr

Bajaj Finserv Healthcare Fund Direct GrowthBajaj Finserv

4.52%

₹15 Cr

Motilal Oswal Small Cap Fund Direct GrowthMOTILAL_OSWAL

3.80%

₹248 Cr

Bajaj Finserv Small Cap Fund Direct GrowthBajaj Finserv

3.35%

₹66 Cr

Motilal Oswal Focused Fund Direct GrowthMOTILAL_OSWAL

3.26%

₹51 Cr

Kotak Manufacture in India Fund Direct GrowthKOTAK_MAHINDRA

3.05%

₹84 Cr

Canara Robeco Manufacturing Fund Direct GrowthCANARA_ROBECO

2.28%

₹37 Cr

PGIM India Retirement Fund Direct GrowthDHFL_PRAMERICA

2.04%

₹2 Cr

Edelweiss Recently Listed IPO Fund Direct GrowthEDELWEISS

2.01%

₹20 Cr

HDFC Innovation Fund Direct GrowthHDFC

1.85%

₹50 Cr

Analyse RUBICON with Orion AI

Ask: "Is Rubicon Research Ltd stock a good buy right now?" — Get RSI, MACD, ROCE + AI recommendation

Analyse with Orion

Want more insights like this?

Get free stock analysis, market insights, and investment ideas delivered to your inbox.

No spam. Unsubscribe anytime.

About Rubicon Research Ltd (RUBICON) Stock

Rubicon Research Ltd is listed on the NSE under the Healthcare sector, Pharmaceuticals industry. ISIN: INE506V01022. Track live share price, technical analysis, RSI, MACD, PE ratio, and smart money holdings on VestAI — India's AI-powered stock analysis platform.